Found: 21
Select item for more details and to access through your institution.
The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00524-7
- By:
- Publication type:
- Article
Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice.
- Published in:
- Scientific Reports, 2015, p. 16756, doi. 10.1038/srep16756
- By:
- Publication type:
- Article
Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 3, p. 668, doi. 10.1038/mt.2013.284
- By:
- Publication type:
- Article
Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 1, p. 233, doi. 10.1038/mt.2013.162
- By:
- Publication type:
- Article
Comparison of Immunogenicity and Safety between a Single Dose and One Booster Trivalent Inactivated Influenza Vaccination in Patients with Chronic Kidney Disease: A 20-Week, Open-Label Trial.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 192, doi. 10.3390/vaccines9030192
- By:
- Publication type:
- Article
Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 666, doi. 10.3390/vaccines8040666
- By:
- Publication type:
- Article
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 573, p. 1, doi. 10.1126/scitranslmed.abd3601
- By:
- Publication type:
- Article
Ad5:Ad48 Hexon Hypervariable Region Substitutions Lead to Toxicity and Increased Inflammatory Responses Following Intravenous Delivery.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 12, p. 2268, doi. 10.1038/mt.2012.162
- By:
- Publication type:
- Article
Gene Delivery of a Mutant TGFβ3 Reduces Markers of Scar Tissue Formation After Cutaneous Wounding.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 12, p. 2104, doi. 10.1038/mt.2010.174
- By:
- Publication type:
- Article
Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactions.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08599-y
- By:
- Publication type:
- Article
Corrigendum: Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine.
- Published in:
- Angewandte Chemie International Edition, 2021, v. 60, n. 31, p. 16741, doi. 10.1002/anie.202105635
- By:
- Publication type:
- Article
Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine.
- Published in:
- Angewandte Chemie International Edition, 2021, v. 60, n. 17, p. 9467, doi. 10.1002/anie.202015362
- By:
- Publication type:
- Article
Adenoviral vectors as novel vaccines for influenza.
- Published in:
- Journal of Pharmacy & Pharmacology, 2015, v. 67, n. 3, p. 382, doi. 10.1111/jphp.12350
- By:
- Publication type:
- Article
A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26499-y
- By:
- Publication type:
- Article
Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus.
- Published in:
- PLoS Biology, 2021, v. 19, n. 12, p. 1, doi. 10.1371/journal.pbio.3001384
- By:
- Publication type:
- Article
Enhancing the protection of influenza virus vaccines with BECC TLR4 adjuvant in aged mice.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-27965-x
- By:
- Publication type:
- Article
Berichtigung: Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 31, p. 16878, doi. 10.1002/ange.202105635
- By:
- Publication type:
- Article
Sterilizing Immunity against SARS‐CoV‐2 Infection in Mice by a Single‐Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist‐Adjuvanted Recombinant Spike Protein Vaccine.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 17, p. 9553, doi. 10.1002/ange.202015362
- By:
- Publication type:
- Article
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.00909
- By:
- Publication type:
- Article
Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.607333
- By:
- Publication type:
- Article
Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors.
- Published in:
- Viruses (1999-4915), 2010, v. 2, n. 10, p. 2290, doi. 10.3390/v2102290
- By:
- Publication type:
- Article